International Society for Pharmacoeconomics and Outcomes Research ( ISPOR )

ISPOR

ISPOR's picture

About International Society for Pharmacoeconomics and Outcomes Research

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) promotes the science of pharmacoeconomics (health economics) and outcomes research (the scientific discipline that evaluates the effect of health care interventions on patient well-being including clinical, economic, and patient-centered outcomes) and facilitates the translation of this research into useful information for health care decision makers to increase the efficiency, effectiveness, and fairness of health care to improve health. Founded in 1995, ISPOR is a non-profit 501(c)(3) public organization for educational and scientific purposes, as defined by the US IRS, and a non-profit research organization under the European Commission 7th Framework Programme.

ISPOR press release, blog etc

10/02/2018 - 12:12 Program Finalized for October 2018 ISPOR Summit on Value Assessment and Healthcare Pricing
10/01/2018 - 10:24 ISPOR Publishes New Global Healthcare Systems Road Map: Egypt Pharmaceuticals
10/01/2018 - 09:32 , the professional society for health economics and outcomes research (HEOR), announced that it has published a new
09/24/2018 - 00:41 Plenary Sessions and Speakers Announced for ISPOR Europe 2018
09/18/2018 - 13:21 Using Next-Generation Sequencing to Target Healthcare Interventions
09/18/2018 - 12:06 New Research Identifies Factors That Influence Physicians Adoption of New Technologies
09/04/2018 - 13:24 ISPOR Announces Keynote Speaker and Program for Upcoming Summit on Value Assessment and Healthcare Pricing
08/28/2018 - 06:02 , the professional society for health economics and outcomes research (HEOR), announced that
08/28/2018 - 05:47 ISPOR Asia Pacific 2018 to Focus on Informing Policy and Strengthening Healthcare Systems
08/28/2018 - 04:38 Keynote Speaker Announced for ISPOR Dubai 2018
08/27/2018 - 07:01 , the professional society for health economics and outcomes research, has won 2 Gold
08/27/2018 - 04:27 ISPOR Recognized for Exceptional Work With dotCOMM and APEX Awards
08/22/2018 - 02:35 New Research: FDA Pilot Compendium Intended to Foster Patient-Focused Drug Development Needs Fine-Tuning
08/22/2018 - 02:22 Study: Members of the Public Willing to Share Limited Healthcare Budget with Less Severely Ill Patients, Even When Not Cost-Effective
08/22/2018 - 00:14 Broad Success for Chinese Pilot Project to Negotiate National Formulary Approval for Innovative Medicines
08/13/2018 - 02:32 ISPOR Announces Launch of New Website and IT Initiative
08/06/2018 - 03:25 ISPOR CEO Named a 2018 PharmaVOICE 100 Honoree
08/06/2018 - 02:19 magazine. She has been recognized as a transformational leader in the Commander and Chief category.